SNRPCP15

Across TCGA pan-cancer cohorts, SNRPCP15 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated SNRPCP15 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher SNRPCP15 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNRPCP15 expression acts as an unfavorable survival marker, although some lineages such as LUSC and KIRP show a favorable association.

THCA, SARC, and ESCA are the cancer types where SNRPCP15 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	III,IV	0.693	0.905	<.001	78	view →
SARC	OS	Tertile	All	0.217	0.841	<.001	45	view →
ESCA	OS	Tertile	IV	0.135	0.568	.031	39	view →
MESO	DFS	Tertile	II,III,IV	0.111	0.411	.006	36	view →
STAD	OS	Tertile	IV	0.174	0.463	.012	24	view →
LUSC	DFS	Tertile	All	0.731	0.356	.006	21	view →
KIRP	OS	Quartile	III,IV	1.000	0.291	.015	19	view →
SKCM	DFS	Tertile	All	0.274	0.617	.006	18	view →
DLBC	OS	Tertile	All	0.053	0.936	<.001	18	view →
UCS	OS	Tertile	All	0.153	0.687	.019	18	view →
ACC	DFS	Tertile	II,III,IV	0.226	0.725	.009	18	view →
HNSC	DFS	Tertile	III,IV	1.000	0.294	.045	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

SNRPCP15–THCA (DFS)

Open the THCA breakdown →